North Sydney Bayer sign up for grabs after budget constraints forced pharma company to give up rights

North Sydney’s Bayer sign is up for lease, after almost 16 years sitting above a tower block on Alfred St in North Sydney.

The sign, which will come down by October, has three sides, the front facing the harbour, as well as the South and North, and sits on top of a building owned by commercial property company, Fivex.

The Bayer sign was the successor of Konica Minolta, a Japanese technology company, which also appeared along the North Sydney CBD skyline.

Mumbrella has been told Bayer was unable to renew its contract for the sign, as the company’s European would not provide them with the budget.

Bayer’s loss of the sky signage spot will allow a new brand to put their name and logo above the building.

Commenting on Bayer’s departure, James Palmer, director of office leasing for Fivex’s agent JLL, told Mumbrella: “It would arguably be bad for the brand having released such a position.

“There is no question that this opportunity has provided deep brand awareness for them. There will be great shock, and it will not go unnoticed when the Bayer sign shines for the last time.

Palmer said he believes the sign is one of the best in Australia.

“The simple reality is that it sits unblocked from the position, and is indeed 3 sided hence more coverage to the north, south (facing CBD) and West where the Bayer crest sits.”

He added: “Fivex would love to see a company that is Australian or who have a large presence in the country such as Bayer.

The static sign is currently for lease, with Fivex seeking a rental rate of 6 figures, in line with current market rates for Sky Signage of the same scale.

Fivex also owns a building on Flinders St in Melbourne, which currently has the Fivex logo on top. It is also looking to lease its signage rights for this too.


Get the latest media and marketing industry news (and views) direct to your inbox.

Sign up to the free Mumbrella newsletter now.



Sign up to our free daily update to get the latest in media and marketing.